Cargando…
A Multidisciplinary Approach for Type 2 Allergic Diseases: What Do Biologics Teach Us?
Autores principales: | Maniscalco, Mauro, Detoraki, Aikaterini, Sarnelli, Giovanni, Nolano, Maria, De Paulis, Amato, Spadaro, Giuseppe, Cantone, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304780/ https://www.ncbi.nlm.nih.gov/pubmed/37373930 http://dx.doi.org/10.3390/jpm13060941 |
Ejemplares similares
-
Exhaled Nitric Oxide as Biomarker of Type 2 Diseases
por: Maniscalco, Mauro, et al.
Publicado: (2023) -
275 Efficacy of Omalizumab in the Treatment of Urticaria-Vasculitis Associated to Churg-Strauss Syndrome: A Case Report
por: Varricchi, Gilda, et al.
Publicado: (2012) -
Early Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review
por: D’Onofrio, Mario, et al.
Publicado: (2023) -
Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study
por: Detoraki, Aikaterini, et al.
Publicado: (2021) -
Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series
por: Detoraki, Aikaterini, et al.
Publicado: (2021)